| |
| |
Preface | |
| |
| |
List of Contributors | |
| |
| |
| |
Macro-anatomy of the prostate | |
| |
| |
| |
| |
Embryology and development of the prostate | |
| |
| |
| |
| |
Molecular control of prostate growth | |
| |
| |
| |
| |
Stromal-epithelial interactions: molecular aspects and relevance to benign prostatic hyperplasia | |
| |
| |
| |
| |
Prostatic adrenoceptors | |
| |
| |
| |
| |
5 Alpha-reductase in prostate disease | |
| |
| |
| |
| |
Pathology of benign prostatic hyperplasia | |
| |
| |
| |
| |
Bladder responses to obstruction | |
| |
| |
| |
| |
Molecular genetics of benign prostatic hyperplasia | |
| |
| |
| |
| |
Population-based studies of benign prostatic hyperplasia | |
| |
| |
| |
| |
Natural history of benign prostatic hyperplasia | |
| |
| |
| |
| |
Evaluating symptoms and functional status | |
| |
| |
| |
| |
Clinical assessment: digital rectal examination | |
| |
| |
| |
| |
Prostate specific antigen and cancer assessment | |
| |
| |
| |
| |
Flow rate and post-void residual issues | |
| |
| |
| |
| |
Urodynamics and benign prostatic hyperplasia | |
| |
| |
| |
| |
Imaging and benign prostatic hyperplasia | |
| |
| |
| |
| |
The role and interpretation of core biopsies in clinical benign prostatic hyperplasia | |
| |
| |
| |
| |
Neurological and neurophysiological assessment | |
| |
| |
| |
| |
Watchful waiting | |
| |
| |
| |
| |
The placebo effect in the treatment of benign prostatic hyperplasia | |
| |
| |
| |
| |
Finasteride therapy for benign prostatic hyperplasia | |
| |
| |
| |
| |
Epristeride: a new 5 alpha-reductase inhibitor for the treatment of benign prostatic hyperplasia | |
| |
| |
| |
| |
Other hormonal treatments | |
| |
| |
| |
| |
Terazosin for the treatment of benign prostatic hyperplasia | |
| |
| |
| |
| |
Doxazosin in the treatment of obstruction of the lower urinary tract | |
| |
| |
| |
| |
Alfuzosin | |
| |
| |
| |
| |
Tamsulosin | |
| |
| |
| |
| |
Combination therapies for benign hyperplasia | |
| |
| |
| |
| |
Phytotherapeutic agents | |
| |
| |
| |
| |
Standard surgical interventions: TUIP/TURP/OPSU | |
| |
| |
| |
| |
Laser prostatectomy | |
| |
| |
| |
| |
Interstitial laser coagulation | |
| |
| |
| |
| |
Hyperthermia treatment for benign prostatic hyperplasia | |
| |
| |
| |
| |
Transurethral thermotherapy | |
| |
| |
| |
| |
Transurethral needle ablation of the prostate | |
| |
| |
| |
| |
High-intensity focused ultrasound | |
| |
| |
| |
| |
Transurethral balloon dilation of the prostate | |
| |
| |
| |
| |
Temporary stents | |
| |
| |
| |
| |
Prostatic endoprosthetics | |
| |
| |
| |
| |
Transurethral electro-vaporization of the prostate | |
| |
| |
| |
| |
Treatment outcomes and their interpretation in benign prostatic hyperplasia | |
| |
| |
| |
| |
Guidelines for diagnosis and management of benign prostatic hyperplasia | |
| |
| |
| |
| |
Economics of benign prostatic hyperplasia | |
| |
| |
| |
| |
Shared care for benign prostatic hyperplasia | |
| |
| |
| |
| |
Prostate diseases beyond the year 2000: present and future burden of prostate diseases | |
| |
| |
| |
Index | |